ALK and lymphoid neoplasm: Anaplastic lymphoma kinase (ALK)-positive diffuse large B-cell lymphoma (ALK+ DLBCL) is a rare novel subtype of DLBCL that was recognized as a separate entity in the 2008 World Health Organization (WHO) classification of lymphoid neoplasms (1).